1-3 of 3
Piera Viero, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicentric Clinical Audit of Chemotherapy Administration for Lymphoprolipherative Diseases in Day Hospital Patient Setting

Giuliana Emilia Muti, MD, Chiara Rusconi, MD, Anna Brizio, MD, Mauro Turrini, MD, Piera Viero, MD, Carmela Iazzetta, Michela Terzi, Claudia Vener, MD, Consuelo Corti, MD, Fabio Giglio, MD, Morena Nazzari, MD, Cristina Fiamenghi, Enrica Morra, MD
Journal: Blood
Blood (2008) 112 (11): 4712.
https://doi.org/10.1182/blood.V112.11.4712.4712
Published: 2008
Journal Articles

The Addition of Rituximab to High Dose Sequential Chemotherapy (HDS) Programs with Autologous Transplantation Significantly Improves the Outcome of Patients with Refractory or Relapsed B-Cell Non Hogkin’s Lymphoma.

Sergio Cortelazzo, MD, Andrea Rossi, MD, Emanuela Carlotti, BSc, Piera Viero, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD
Journal: Blood
Blood (2005) 106 (11): 2084.
https://doi.org/10.1182/blood.V106.11.2084.2084
Published: 2005
Journal Articles

Time- and Dose-Response Relationships of Imatinib Mesylate (Glivec) Therapy for Chronic Hypereosinophilic Syndromes.

Renato Bassan, MD, Sara Acerboni, BSc, Silvia Mappa, MD, Piera Viero, MD, Federica Delaini, BSc, Giuseppe Rossi, Valentina Rossi, A. Vannucchi, MD, Eros Di Bona, MD, Emanuela Ruggeri, Anna Salvi, Ursula Giussani, BSc, Francesca Rancati, MD, Tamara Intermesoli, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD
Journal: Blood
Blood (2005) 106 (11): 2596.
https://doi.org/10.1182/blood.V106.11.2596.2596
Published: 2005